Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Neurol Sci ; 44(8): 2871-2881, 2023 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-36905450

RESUMEN

BACKGROUND: Intravenous immune globulin (IVIg) is frequently used in some neurological diseases and is also the first-line therapy in Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy. We aimed to evaluate the frequency and characteristics of headaches, which is one of the most common side effects of IVIg treatment. METHODS: Patients who received IVIg treatment for neurological diseases were prospectively enrolled in 23 centers. Firstly, the characteristics of patients with and without IVIg-induced headaches were analyzed statistically. Then, patients with IVIg-induced headaches were classified into three subgroups determined by their history: no primary headache, tension-type headache (TTH), and migraine. RESULTS: A total of 464 patients (214 women) and 1548 IVIg infusions were enrolled between January and August 2022. The frequency of IVIg-related headaches was 27.37% (127/464). A binary logistic regression analysis performed with significant clinical features disclosed that female sex and fatigue as a side effect were statistically more common in the IVIg-induced headache group. IVIg-related headache duration was long and affected daily living activities more in patients with migraine compared to no primary headache and TTH groups (p = 0.01, respectively). CONCLUSION: Headache is more likely to occur in female patients receiving IVIg and those who develop fatigue as a side effect during the infusion. Clinicians' awareness of IVIg-related headache characteristics, especially in patients with migraine, may increase treatment compliance.


Asunto(s)
Trastornos Migrañosos , Enfermedades del Sistema Nervioso , Cefalea de Tipo Tensional , Femenino , Humanos , Inmunoglobulinas Intravenosas/efectos adversos , Estudios Prospectivos , Cefalea/inducido químicamente , Cefalea/tratamiento farmacológico , Trastornos Migrañosos/tratamiento farmacológico
2.
Neurosciences (Riyadh) ; 18(1): 70-3, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23291801

RESUMEN

Sarcoidosis is a multisystem inflammatory disease of unknown etiology. Isolated neurosarcoidosis without signs of systemic involvement has rarely been reported in the literature. We report a case of isolated neurosarcoidosis that presented with psychiatric symptoms and headache. Cranial MRI revealed bilateral diffuse high intensity lesions in the deep white matter, with a linear contrast enhancement of perivascular areas. Histological examination of a stereotactic brain biopsy specimen demonstrated noncaseating granulomas. Further research did not reveal any evidence of systemic disease. The patient was treated with corticosteroids and responded well to medical therapy. The diagnosis of isolated neurosarcoidosis is a challenge and may require histological examination.


Asunto(s)
Enfermedades del Sistema Nervioso Central/complicaciones , Enfermedades del Sistema Nervioso Central/patología , Trastornos Psicóticos/etiología , Trastornos Psicóticos/patología , Sarcoidosis/complicaciones , Sarcoidosis/patología , Adulto , Biopsia , Encéfalo/patología , Humanos , Leucoencefalopatías/complicaciones , Leucoencefalopatías/patología , Imagen por Resonancia Magnética , Masculino
3.
Brain Res ; 1732: 146652, 2020 04 01.
Artículo en Inglés | MEDLINE | ID: mdl-31926908

RESUMEN

The brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism may cause impairment in short-term motor learning by reducing activity-dependent BDNF expression, which causes alterations in synaptic plasticity by changing glutamatergic and GABAergic synaptic transmissions. Sensory-motor integration (SMI) plays an important role in motor learning. In this study, we investigated the role of this polymorphism on SMI during a complex motor learning practice. Forty-three healthy participants performed standardized 5-day basketball shooting exercises under supervision. Electrophysiologic SMI studies were performed before the first day exercise (T0) and after the first and fifth day exercises (T1 and T2, respectively). SMI was studied using electrical median nerve stimulation at the wrist, followed by transcranial magnetic stimulation (TMS) of the contralateral motor cortex with various inter-stimulus intervals (ISIs). Recordings were made from the thenar and forearm flexor muscles. Participants were divided into two groups according to their BDNF genotype. Group 1 consisted of 26 subjects with the Val66Val genotype and group 2 included 17 subjects with the BDNF Met allele. Group 2 had a lower increase in basketball scores at day 5. Moreover, they had higher afferent facilitation for the responses recorded from both thenar and forearm flexor muscles at T1, but these changes could not be maintained until T2. This non-persistent early hyper-responsivity of the sensory-motor cortex in subjects with the BDNF Met allele might be explained by a transient upsurge of cortical excitability to compensate the insufficient cortical plasticity during motor learning, which could be considered as a sign of lower performance in motor skill learning.


Asunto(s)
Factor Neurotrófico Derivado del Encéfalo/genética , Potenciales Evocados Motores/fisiología , Aprendizaje/fisiología , Desempeño Psicomotor/fisiología , Adolescente , Adulto , Rendimiento Atlético , Baloncesto/fisiología , Estimulación Eléctrica , Femenino , Voluntarios Sanos , Humanos , Masculino , Polimorfismo de Nucleótido Simple , Estimulación Magnética Transcraneal , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA